ADT 2007 Annual Report Download - page 78

on the Company’s performance share program, see the discussion under the heading Accelerated
Fiscal Year 2008 Equity Awards in the Compensation Discussion and Analysis.
As described in the Compensation Discussion and Analysis, stock options and restricted shares
held by certain Tyco employees that were granted prior to September 29, 2006 were adjusted so that
immediately after the Separation the employees held stock options and restricted shares of each of
Tyco, Covidien and Tyco Electronics. As a result, each of the named executive officers holds stock
options and/or restricted shares of Covidien and Tyco Electronics that are not included in the table
above. As a result of the Separation:
• Mr. Breen received 2,251,169 options to purchase Covidien common stock with exercise prices
ranging from $12.76 to $57.40, all of which will vest by November 22, 2008; and 2,251,169
options to purchase Tyco Electronics common stock with exercise prices ranging from $11.56 to
$52.02, all of which will vest by November 22, 2008. In addition, Mr. Breen received
110,818 shares of restricted stock of each of Covidien and Tyco Electronics, all of which will vest
by September 30, 2008.
• Mr. Coughlin received 149,248 options to purchase Covidien common stock with exercise prices
ranging from $36.99 to $45.66, all of which will vest by November 22, 2008; and 149,248 options
to purchase Tyco Electronics common stock with exercise prices ranging from $33.52 to $41.38,
all of which will vest by November 22, 2008. In addition, Mr. Coughlin received 56,417 shares of
restricted stock of each of Covidien and Tyco Electronics, all of which will vest by September 30,
2008.
• Mr. Evard received 135,814 options to purchase Covidien common stock with exercise prices
ranging from $18.20 to $45.66, all of which will vest by November 22, 2008; and 135,814 options
to purchase Tyco Electronics common stock with exercise prices ranging from $16.50 to $41.38,
all of which will vest by November 22, 2008. In addition, Mr. Evard received 10,852 shares of
restricted stock of each of Covidien and Tyco Electronics, all of which will vest by September 30,
2008.
• Mr. Davidson received 88,552 options to purchase Covidien common stock with exercise prices
ranging from $35.10 to $45.66, all of which will vest by November 22, 2008; and 88,552 options
to purchase Tyco Electronics common stock with exercise prices ranging from $31.81 to $41.38,
all of which will vest by November 22, 2008. In addition, Mr. Davidson received 11,477 shares of
restricted stock of each of Covidien and Tyco Electronics, all of which will vest by September 30,
2008.
• Mr. Gursahaney received 6,215 shares of restricted stock of each of Covidien and Tyco
Electronics, all of which will vest by January 2, 2008.
• Mr. Lytton received 329,838 options to purchase Covidien common stock with exercise prices
ranging from $17.54 to $45.66, of which 309,109 have vested and 20,729 were cancelled upon his
termination from the Company; and 329,838 options to purchase Tyco Electronics common stock
with exercise prices ranging from $15.90 to $41.38, of which 309,109 have vested and 20,729 were
cancelled upon his termination from the Company. In addition, Mr. Lytton received
32,744 shares of restricted stock of each of Covidien and Tyco Electronics, of which 23,473 were
vested and 9,271 were cancelled in each company upon his termination.
• Mr. Robinson received 22,000 shares of restricted stock of each of Covidien and Tyco
Electronics, all of which have vested.
58 2008 Proxy Statement